Nature, Published online: 20 August 2025; doi:10.1038/d41586-025-02606-7

Many cancer-driving mutations disable a key checkpoint in the cell’s cycle between growth and division, resulting in unchecked activity of the E2F family of transcription factor proteins. A set of compounds developed to directly block key regulators of the cell cycle called cyclins can suppress the growth of cancers driven by high E2F activity.


From Nature via this RSS feed